RECRUITING

An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This randomized controlled trial (RCT) will evaluate the feasibility and efficacy of Pink Cloud, a mobile health application designed to support recovery from substance and alcohol use disorders (SUD/AUD). The app provides access to over 245,000 in-person and virtual 12-Step meetings, along with features such as a sobriety counter, daily planner, and personal inventory tools. In this study, 1,410 participants in various stages of recovery will be randomly assigned to receive either access to the Pink Cloud app or to a control condition. Participants will complete follow-up assessments at 1, 3, and 6 months. Primary outcomes include number of days sober and frequency of drug and alcohol problems. Secondary outcomes include meeting attendance, proportion of sober individuals in one's social network, and engagement in recovery-related activities. The investigators hypothesize that participants in the Pink Cloud group will report more days sober and fewer substance use problems than those in the control group, and that they will also report attending more meetings, having a greater proportion of sober peers, and engaging more frequently in recovery activities.

Official Title

Digital Aftercare Assessed: An Evaluation of the Pink Cloud Application in Post-Treatment Substance Use Disorder Support

Quick Facts

Study Start:2025-07-09
Study Completion:2026-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07042451

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participant is 18 years of age or older
  2. * Participant is willing to attend a 12-Step or peer-to-peer recovery meeting (in person or virtual) within the next week
  3. * Participant owns a personal smartphone with cellular service
  4. * Participant is a permanent resident of the United States
  5. * Participant feels comfortable reading and understanding written English in everyday situations
  6. * Participant has consumed alcohol and/or used drugs (excluding tobacco or prescribed medication) at some point in their life, but not within the past couple of days
  7. * Participant is not currently attending outpatient or residential treatment for substance and/or alcohol use
  8. * Participant does not have a plan to enter substance and/or alcohol treatment in the next 30 days
  9. * Participant has been invited by the research team to either the intervention or control condition and redeemed their subscription code.
  10. * Informed consent is provided
  1. * Participant is younger than 18 years of age
  2. * Participant is unwilling to attend a 12-Step or peer-to-peer recovery meeting (in person or virtual) within the next week
  3. * Participant does not own a personal smartphone with cellular service
  4. * Participant is not a permanent resident of the United States
  5. * Participant does not feel comfortable reading and understanding written English in everyday situations
  6. * Participant has consumed alcohol or used drugs (excluding tobacco or prescribed medication) within the past couple of days
  7. * Participant has never consumed alcohol or used drugs
  8. * Participant is currently attending outpatient or residential treatment for substance and/or alcohol use
  9. * Participant has a plan to enter substance and/or alcohol treatment in the next 30 days
  10. * Participant was not invited by the research team or did not redeem their assigned subscription code
  11. * Informed consent is not provided

Contacts and Locations

Study Contact

Joseph LaBrie, Ph.D.
CONTACT
3103385238
jlabrie@lmu.edu

Study Locations (Sites)

Loyola Marymount
Los Angeles, California, 90045
United States

Collaborators and Investigators

Sponsor: Loyola Marymount University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-07-09
Study Completion Date2026-08

Study Record Updates

Study Start Date2025-07-09
Study Completion Date2026-08

Terms related to this study

Additional Relevant MeSH Terms

  • Substance Use